Drug Interactions between Olysio and Truvada
This report displays the potential drug interactions for the following 2 drugs:
- Olysio (simeprevir)
- Truvada (emtricitabine/tenofovir disoproxil)
Interactions between your drugs
No interactions were found between Olysio and Truvada. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Olysio
A total of 196 drugs are known to interact with Olysio.
- Olysio is in the drug class protease inhibitors.
- Olysio is used to treat Hepatitis C.
Truvada
A total of 245 drugs are known to interact with Truvada.
- Truvada is in the drug class antiviral combinations.
- Truvada is used to treat the following conditions:
Drug and food interactions
simeprevir food
Applies to: Olysio (simeprevir)
ADJUST DOSING INTERVAL: Food significantly enhances the oral bioavailability of simeprevir, although the type of food does not seem to matter. In healthy study subjects, administration of simeprevir after a high-fat, high-caloric (928 kcal) breakfast increased systemic exposure (AUC) by 61% and delayed absorption by 1 hour, while administration after a normal caloric (533 kcal) breakfast increased AUC by 69% and delayed absorption by 1.5 hours.
MANAGEMENT: To ensure maximal oral absorption, simeprevir should be administered with food.
References (1)
- (2013) "Product Information. Olysio (simeprevir)." Janssen Pharmaceuticals
tenofovir food
Applies to: Truvada (emtricitabine / tenofovir disoproxil)
Food enhances the oral absorption and bioavailability of tenofovir, the active entity of tenofovir disoproxil fumarate. According to the product labeling, administration of the drug following a high-fat meal increased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of tenofovir by approximately 14% and 40%, respectively, compared to administration in the fasting state. However, administration with a light meal did not significantly affect the pharmacokinetics of tenofovir compared to administration in the fasting state. Food delays the time to reach tenofovir Cmax by approximately 1 hour. Tenofovir disoproxil fumarate may be administered without regard to meals.
References (1)
- (2001) "Product Information. Viread (tenofovir)." Gilead Sciences
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.